The obtained results indicate the potential for utilizing the novel OGF-Gem conjugate in the development of safe drugs that may inhibit the metastasis of oncological diseases, in contrast to the commonly used chemotherapeutic agents such as gemcitabine, which also demonstrate high cytotoxicity against non-tumor transformed cells. Here, GEM is linked to neoplasm.